Top 10 Healthcare Companies in the World in 2021 by Revenue

Johnson & Johnson, F. Hoffmann-La Roche Ltd, Novartis AG, Bayer AG, and GSK plc are the top 5 healthcare companies in the world in 2021 by revenue. Cumulatively, the top 10 healthcare companies in the world generated revenue of $513,834 million, with average revenue growth of 13.4%, the highest revenue was generated by Johnson & Johnson ($93,775 million), followed by F. Hoffmann-La Roche Ltd ($68,710 million) and Novartis AG ($52,877 million), while the lowest increases were registered by 3M Co ($35,355 million). As of FY2021, the highest revenue growth was registered by AstraZeneca Plc (40.6%), followed by Abbott Laboratories (24.5%), while GSK plc registered the lowest revenue growth of 0.04%.In terms of the geographical split, 6 out of the world's top 10 healthcare companies are based in Europe, while 4 are based in North America. They employed a total of 1,282,377 people in 2021. The United States of America-based Johnson & Johnson is the leading healthcare company in the world (by revenue). The company reported revenues of $93,775 million for the fiscal year ended January 2021 (FY2021), an increase of 13.6% over FY2020, due to increased revenue from oral care, skin health/beauty, wound care/other, and OTC product categories. The company develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases and employs 141,700 people. Switzerland-based F. Hoffmann-La Roche Ltd is one of the leading healthcare companies in the world (by revenue). The company reported revenues of $68710 million for the fiscal year ended December 2021 (FY2021), an increase of 7.7% over FY2020, and recorded a CAGR of 4.2% during 2019-21. The company develops novel medicines that improve the standard of care in infectious diseases, cancer, immunology, ophthalmology, neuroscience and other conditions. It also specializes in in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management. It is active in more than 100 countries in North America, Europe, Latin America, Asia, Africa and Oceania, and employs 100,920 people.